Literature DB >> 6727703

Quantitative studies on the influence of leukocytes on the vascular resistance in a skeletal muscle preparation.

M Braide, B Amundson, S Chien, U Bagge.   

Abstract

The effects of leukocytes on vascular resistance and capillary filtration coefficient (CFC) of the maximally vasodilated vascular bed of rat hindquarters were measured using servocontrolled isogravimetry . After determination of the pre- and postcapillary resistances and CFC with a cell-free perfusate, a leukocyte bolus was introduced (0.5 to 9 X 10(6) cells/100 g tissue). Experiments were performed at three flows: 0.7-0.9, 1.4-1.6, and 2.4-3.7 ml/(min X 100 g tissue). Changes in vascular resistance were calculated from continuous pressure-flow recordings during a 10-min period, followed by a CFC measurement. Leukocytes were counted in the effluent for calculation of the number of cells remaining in the vascular bed. Leukocyte infusion caused a transient increase of the precapillary resistance (Ra) by as much as 72% after infusion of 9 X 10(6) cells/100 g tissue at 0.7-0.9 ml/(min X 100 g tissue). After the initial peak the Ra usually fell to a lower, constant, level, but was still clearly elevated (maximum 23%) at the low flows of 0.7-0.9 and 1.4-1.6 ml/(min X 100 g tissue). This sustained increase of Ra was positively related to the number of cells remaining in the vasculature. At high flows of 2.4-3.7 ml/(min X 100 g tissue) the Ra increase was very small, irrespective of the number of cells infused or remaining in the vascular bed. These findings, together with the fact that CFC decreased proportionally to the sustained increase of Ra, indicate that the effect of leukocytes on Ra was due to a pressure-dependent occlusion of the microvasculature.

Entities:  

Mesh:

Year:  1984        PMID: 6727703     DOI: 10.1016/0026-2862(84)90064-5

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  17 in total

Review 1.  Leg ulceration in venous disease.

Authors:  S K Shami; D A Shields; J H Scurr; P D Smith
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

Review 2.  Blood viscosity and circulatory shock.

Authors:  H J Voerman; A B Groeneveld
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

3.  Microvascular injury and repair in acute human bacterial pyelonephritis.

Authors:  B Iványi; W Thoenes
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  Causes of venous ulceration: a new hypothesis.

Authors:  P D Coleridge Smith; P Thomas; J H Scurr; J A Dormandy
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-18

5.  Analysis of the effects of measured white blood cell entrance times on hemodynamics in a computer model of a microvascular bed.

Authors:  B M Fenton; D W Wilson; G R Cokelet
Journal:  Pflugers Arch       Date:  1985-04       Impact factor: 3.657

6.  Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats.

Authors:  J P Roesner; D A Vagts; T Iber; C Eipel; B Vollmar; G F E Nöldge-Schomburg
Journal:  Intensive Care Med       Date:  2006-08-23       Impact factor: 17.440

7.  Intravital microscopy of capillary hemodynamics in sickle cell disease.

Authors:  H H Lipowsky; N U Sheikh; D M Katz
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

8.  Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion.

Authors:  B Vollmar; J Glasz; R Leiderer; S Post; M D Menger
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  Abnormal flow properties of white blood cells in patients with severe ischaemia of the leg.

Authors:  G B Nash; P R Thomas; J A Dormandy
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-18

10.  Neutrophil regulation of splanchnic blood flow after hemorrhagic shock.

Authors:  R H Turnage; K M Kadesky; T Rogers; R Hernandez; L Bartula; S I Myers
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.